NCID by Mahalo
Secure ePRO for Research
Only for iPhone
Free · Designed for iPhone. Not verified for macOS.
iPhone
Description
Designed for clinical research teams and study participants, this app provides a secure and intuitive platform for Electronic Patient Reported Outcomes (ePROs). Participants can complete surveys, log symptoms, and upload images directly from their mobile devices, while research teams benefit from real-time data collection and monitoring.
Key Features:
User-friendly surveys with various question types (Yes/No, multiple choice, sliders, etc.)
Support for parent-child profiles with unique participant IDs
Trigger-based surveys (e.g., Day 1, Day 2, Day 14 assessments)
Secure data storage with real-time backup
In-app photo capture and upload
Push notifications and reminders
Role-based access for study teams, investigators, and participants
Full compliance with data protection and ethical guidelines
This app is ideal for multi-site and longitudinal studies.
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
- minor bug fixes
The developer, Mahalo Digital Ventures, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Linked to You
The following data may be collected and linked to your identity:
- Health & Fitness
- Contact Info
- User Content
- Identifiers
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Mahalo Digital ventures inc.
- Size
- 63.3 MB
- Category
- Health & Fitness
- Compatibility
Requires iOS 13.4 or later.
- iPhone
Requires iOS 13.4 or later. - iPod touch
Requires iOS 13.4 or later. - Mac
Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- iPhone
- Languages
- English
- Age Rating
4+
- 4+
- Copyright
- ©2024 Mahalo Digital Ventures, Inc.